Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation

Czoski-Murray, C., Warren, E., Chilcott, J., Beverley, C., Psyllaki, M.A. and Cowan, J. (2004) Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation. Technical Report. Gray Publishing , Tunbridge Wells.

Abstract

Metadata

Authors/Creators:
  • Czoski-Murray, C.
  • Warren, E.
  • Chilcott, J.
  • Beverley, C.
  • Psyllaki, M.A.
  • Cowan, J.
Copyright, Publisher and Additional Information: Copyright: Queen’s Printer and Controller of HMSO 2004 HTA reports may be freely reproduced for the purposes of private research and study and may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Violations should be reported to hta@soton.ac.uk Applications for commercial reproduction should be addressed to HMSO, The Copyright Unit, St Clements House, 2-16 Colegate, Norwich, NR3 1BQ
Keywords: Diabetes mellitus, Clinical effectiveness, Cost effectiveness, Pioglitazone, Rosiglitazone, Hypoglycemic agents
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
Depositing User: Diana Papaioannou
Date Deposited: 08 Dec 2006
Last Modified: 30 Jul 2015 00:36
Published Version: http://www.hta.ac.uk/1315
Status: Published
Publisher: Gray Publishing
Identification Number: ISSN 1366-5278

Share / Export

Statistics